Autonomix Medical (AMIX) Gains from Investment Securities (2023 - 2024)
Autonomix Medical (AMIX) posted quarterly Gains from Investment Securities of $3.0 million for Q1 2024, up 1400.0% quarter-over-quarter from $200000.0 in Q4 2023.
Autonomix Medical (AMIX) Gains from Investment Securities (2023 - 2024) Analysis & Trends
Autonomix Medical (AMIX) has reported Gains from Investment Securities for 2 consecutive years, with $3.0 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Gains from Investment Securities changed N/A year-over-year to $3.0 million; the TTM figure through Mar 2025 stood at $3.0 million (changed N/A YoY), while the FY2024 annual figure was $3.4 million, changed N/A from the prior year.
- Gains from Investment Securities advanced to $3.0 million in Q1 2024 per AMIX's latest filing, from $200000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $3.0 million in Q1 2024 and bottomed at $200000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Autonomix Medical | 2.38 Mn | -4.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 239,000.00 |
| Sep 30, 2023 | 239,000.00 |